Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Nicolò Borsellino"'
Autor:
Paolo Tralongo, Sebastiano Bordonaro, Giuseppe Di Lorenzo, Ugo De Giorgi, Nicolò Borsellino, Gaetano Facchini, Sabrina Rossetti, Giuseppe Fornarini, Vito Longo, Antonino Carmelo Tralongo, Francesca Caspani, Massimiliano Spada, Nicola Calvani, Paolo Carlini
Publikováno v:
Current Urology, Vol 17, Iss 3, Pp 153-158 (2023)
Abstract. Background. To evaluate the effectiveness and safety of cabazitaxel in castration-resistant prostate cancer patients aged ≥80 years, we performed a retrospective study on a sample of patients from 11 Italian cancer centers. Materials and
Externí odkaz:
https://doaj.org/article/03800b30400142778963f77391737093
Publikováno v:
Case Reports in Oncology, Vol 15, Iss 1, Pp 312-317 (2022)
Prostate cancer is the most frequent malignant tumor in male. Despite its incidence increased in the last few years, the mortality is gradually decreasing, even in patients with metastatic prostate cancer (mPC). Unfortunately, prolongation of surviva
Externí odkaz:
https://doaj.org/article/1cf389de5c12438c9d9cb4eac1f7e86e
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 722-729 (2020)
PURPOSE This descriptive investigation was undertaken at three oncology units to report queries, needs, and fears related to severe acute respiratory syndrome coronavirus 2 (COVID-19) of patients with cancer and to avoid uncontrolled treatment delays
Externí odkaz:
https://doaj.org/article/c8c64c80841f45df91fc1e582e63b392
Autor:
Maria Rosaria Valerio, Pietro Spadaro, Concetta Arcanà, Nicolò Borsellino, Calogero Cipolla, Paolo Vigneri, Dario Piazza, Vittorio Gebbia
Publikováno v:
Future Science OA, Vol 7, Iss 10 (2021)
A retrospective analysis of 70 patients with triple-negative or hormone-resistant advanced breast carcinoma who had not previously received chemotherapy was carried out. Patients received oral vinorelbine 60 mg/m2 on day 1 and 8, plus capecitabine 10
Externí odkaz:
https://doaj.org/article/da93e496c4ea43c8a2d8f62f60f5ed76
Autor:
Gaetano Facchini, Sabrina Rossetti, Massimiliano Berretta, Carla Cavaliere, Sarah Scagliarini, Maria Giuseppa Vitale, Chiara Ciccarese, Giuseppe Di Lorenzo, Erica Palesandro, Vincenza Conteduca, Umberto Basso, Emanuele Naglieri, Azzurra Farnesi, Michele Aieta, Nicolò Borsellino, Leonardo La Torre, Gelsomina Iovane, Lucia Bonomi, Donatello Gasparro, Enrico Ricevuto, Michele De Tursi, Rocco De Vivo, Giovanni Lo Re, Francesco Grillone, Paolo Marchetti, Ferdinando De Vita, Claudio Scavelli, Claudio Sini, Salvatore Pisconti, Anna Crispo, Vittorio Gebbia, Antonio Maestri, Luca Galli, Ugo De Giorgi, Roberto Iacovelli, Carlo Buonerba, Giacomo Cartenì, Carmine D’Aniello
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-11 (2019)
Abstract Background This multi-institutional retrospective real life study was conducted in 22 Italian Oncology Centers and evaluated the role of Axitinib in second line treatment in not selected mRCC patients. Methods 148 mRCC patients were evaluate
Externí odkaz:
https://doaj.org/article/ce45764abe174be68515afe7c66b3135
Autor:
Paolo Tralongo, Sebastiano Bordonaro, Giuseppe Di Lorenzo, Ugo De Giorgi, Nicolò Borsellino, Gaetano Facchini, Sabrina Rossetti, Giuseppe Fornarini, Vito Longo, Antonino Carmelo Tralongo, Francesca Caspani, Massimiliano Spada, Nicola Calvani, Paolo Carlini
Publikováno v:
Current Urology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e967fe0be3308baeafdefa85fa7e7f4
https://doi.org/10.1097/cu9.0000000000000081
https://doi.org/10.1097/cu9.0000000000000081
Publikováno v:
Tumori Journal. :030089162211325
Introduction: This monocentric, single-arm, retrospective study investigated the role of stereotactic body radiotherapy in patients with metastatic castration resistant prostate cancer who experienced oligoprogression during androgen receptor targete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96d8317dedcd4582bc98e70c50e958c4
https://doi.org/10.1177/03008916221132592
https://doi.org/10.1177/03008916221132592
Autor:
Giovanni Bozza, Sante Romito, Salvatore Pisconti, Mariangela Ciccarese, Paola Schiavone, Palma Fedele, Michele Aieta, Giuseppe Colucci, Goim, Giammarco Surico, Saverio Cinieri, Laura Orlando, R. Forcignanò, Vito Lorusso, Evaristo Maiello, Valeria Saracino, Antonio Febbraro, Ferdinando Riccardi, Roberto Bordonaro, Antonio Rinaldi, Nicolò Borsellino, Giuseppina Cilenti
Publikováno v:
The Breast Journal. 26:1857-1859
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd5ecfa3ece299999a58e188aae14a4a
https://doi.org/10.1111/tbj.13856
https://doi.org/10.1111/tbj.13856
Autor:
Salvatore Pisconti, Vittorio Gebbia, Michele Aieta, Erica Palesandro, Emanuele Naglieri, Donatello Gasparro, Nicolò Borsellino, Antonio Maestri, Anna Crispo, A. Farnesi, Francesco Grillone, Lucia Bonomi, Gaetano Facchini, Giovanni Re, Giacomo Cartenì, Rocco De Vivo, Sarah Scagliarini, Giuseppe Di Lorenzo, Umberto Basso, Ferdinando De Vita, Enrico Ricevuto, Gelsomina Iovane, Claudio Sini, Maria Giuseppa Vitale, Luca Galli, Carla Cavaliere, Sabrina Rossetti, Carmine D'Aniello, Michele De Tursi, Carlo Buonerba, Chiara Ciccarese, Roberto Iacovelli, Claudio Scavelli, Ugo De Giorgi, Paolo Marchetti, Vincenza Conteduca, Leonardo La Torre, Massimiliano Berretta
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-11 (2019)
Journal of Translational Medicine
Università degli studi di Foggia-IRIS
Journal of Translational Medicine
Università degli studi di Foggia-IRIS
Background This multi-institutional retrospective real life study was conducted in 22 Italian Oncology Centers and evaluated the role of Axitinib in second line treatment in not selected mRCC patients. Methods 148 mRCC patients were evaluated. Accord
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d12acb662f5d5d700c929cd93d0d7e2f
http://link.springer.com/article/10.1186/s12967-019-2047-4
http://link.springer.com/article/10.1186/s12967-019-2047-4
Autor:
Pietro Spadaro, Calogero Cipolla, Concetta Arcanà, Maria Rosaria Valerio, Dario Piazza, Paolo Vigneri, Vittorio Gebbia, Nicolò Borsellino
Publikováno v:
Future Science OA
A retrospective analysis of 70 patients with triple-negative or hormone-resistant advanced breast carcinoma who had not previously received chemotherapy was carried out. Patients received oral vinorelbine 60 mg/m2 on day 1 and 8, plus capecitabine 10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::693c264bb617f61f89018beb53a6a1a1
https://hdl.handle.net/20.500.11769/548850
https://hdl.handle.net/20.500.11769/548850
